From market research to prototype development to business strategy and fundraising, we connect you to the right resources in our broad network of individuals and organizations. These are both local and international entities with expertise in healthcare technology commercialization.
The OhioHealth Research and Innovation Institute (OHRI) Commercialization Services office acts as your partner in taking your healthcare solution to the marketplace.
OHRI is unique in that we don’t take ownership. Your intellectual property remains your own. Our services are here to support and encourage you to pursue your innovative ideas to improve patient care.
We encourage OhioHealth physicians, surgeons, nurses and clinicians to bring us their ideas for improving patient care.
Our $5 million fund provides financial support to innovators — OhioHealth physicians, nurses and associates — for the commercialization of new clinical innovations.
Funding can be applied to early and late stage innovations that:
The fund helps decrease the time it takes to get a clinical innovation idea developed and into the commercial marketplace where the product can be used for patient care.
The fund also supports OhioHealth physicians, nurses and associates working to bring their product ideas to life, while also giving them the opportunity to retain ownership of their intellectual property.
The OhioHealth Innovation Development Fund is managed by the OhioHealth Commercialization Office in partnership with Rev1 Ventures, a Columbus-based company dedicated to investing in Ohio’s brightest entrepreneurs and most promising ideas. OhioHealth began its relationship with Rev1 Ventures in 2006.
Up to $75,000 per project is available for maturing new clinical innovation products, with the potential for additional funding of up to $500,000 as part of our Early Stage Venture Fund.
Any OhioHealth physician with privileges or any OhioHealth associate who is the primary innovator on the project may be eligible for funding through the Innovation Development Fund.
After you have filled out an innovation questionnaire and received a commercialization plan, your innovation will be assessed for its commercial potential through Commercialization Services and Rev 1 Ventures for presentation to our Innovation Investment & Advisory Committee. The Innovation Investment & Advisory Committee and OhioHealth will decide if the innovation would benefit from funding. Upon a funding decision, you will be contacted to discuss the next steps.
For more information or to set up a time to start your commercialization project, contact:
Christopher Willson, PhD, MBA
Director of Research Support Services & Commercialization
Sara Johnson, PhD